Phase 1, Randomised, Open Label Trial Assessing PK and Safety of Low-Dose CAM2038 q4w in HV

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1005072

• Contact name

  Per Gustavsson

• Contact email

  regulatory@camurus.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2022-000393-26

• Research summary

  Publication of this data is currently deferred.

• REC name

  London - Brent Research Ethics Committee

• REC reference

  22/LO/0156

• Date of REC Opinion

  31 Mar 2022

• REC opinion

  Further Information Favourable Opinion